Novotech

Amgen Donates $1 Million to Help Japanese Disaster Victims

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Connected Diagnostic Ecosystems: The Future of Laboratory Efficiency

In this article This article contains: What is the current landscape...

Critical Factors When Selecting Central Lab Services for European Clinical Trials

In This Article: This article contains: Navigating the Complexities of...

Best Medical Carts on Wheels for Clinicians

In This Article This article contains: Tryten S5 Tablet Cart ...
- Advertisement -

Amgen announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen and the Amgen Foundation will distribute the funds to both Direct Relief International and International Medical Corps to bring basic needs and vital health services to those affected in Japan. Amgen has a long history in Japan with our partnership with Kirin Holdings and its pharmaceutical affiliate Kyowa Hakko Kirin that began in 1984, and more recently partnerships with Takeda Pharmaceutical and Daiichi Sankyo.

Kevin Sharer, Amgen’s chairman and chief executive officer said, The earthquake and subsequent tsunami in Japan have been devastating to so many people throughout the country. Our sincere sympathy goes to all of those in Japan affected by this tragedy

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Connected Diagnostic Ecosystems: The Future of Laboratory Efficiency

In this article This article contains: What is the current landscape...

Critical Factors When Selecting Central Lab Services for European Clinical Trials

In This Article: This article contains: Navigating the Complexities of...

Best Medical Carts on Wheels for Clinicians

In This Article This article contains: Tryten S5 Tablet Cart ...

How Can Integrative Cardiologists Use Custom Supplement Formulations for Heart Health Patients?

In This Article This article contains: The Limitations of One-Size-Fits-All...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป